Evidence map›Paper›PMID 38004571›Full record

ArticlePharmaceutics2023

Evidence of Reliable Gastro-Resistance of Novel Enteric Ready-to-Fill Capsules Simplifying Pharmaceutical Manufacturing.

Jesús Alberto Afonso Urich, Anna Fedorko, Bettina Hölzer, Johannes Khinast

Abstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jesús Alberto Afonso UrichResearch Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria.ORCID 0009-0009-2097-1764
Anna FedorkoResearch Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria.
Bettina HölzerEvonik Operations GmbH, Nutrition & Care, Kirschenallee, 64293 Darmstadt, Germany.ORCID 0009-0007-4670-4600
Johannes KhinastResearch Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing delayed-release formulations for acid-sensitive actives can be a costly and time-consuming process. However, ready-to-fill functional capsules, such as EUDRACAP

Indexed as

acid-labile drugsdelayed-release formulationenteric-coated capsulestargeted drug delivery

Identifiers

PMID38004571
PMCPMC10675293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.